“Technology Platforms for 3D Cell Culture”
COST 16119 CellFit, Annual Meeting
Albena, Bulgaria, 12-14 September 2017
The event is designed to address current and emerging technologies for three dimensional (3D) cell culture and the formation of tissue constructs in the laboratory, that enable a greater recapitulation of human physiology in vitro. Specifically, it will cover technology platforms to build surrogates of real tissue and consider the physical and chemical cues involved when creating such in vitro models. The event will also highlight exciting opportunities and latest innovations, tissue constructs, organoid techniques, as well as key developments in 3D and 4D bio-printing, fluid flow, and the ongoing debate of 2D vs 3D cell culture.
With a focus on successes and emerging technologies, the conference will showcase how 3D cell culture technologies are revolutionizing basic research, drug discovery and toxicity screening, as well as how it is emerging as an invaluable tool in new areas such as stem cell research and regenerative medicine. Delegates will discuss the challenges and future directions of these techniques, reproducibility, and robustness and compatibility with analytical methods. Furthermore, the need for in-depth characterization and validation alongside real tissues is considered with the goal of reducing the number of animals used and allowing a safe translation from bench to clinical applications.
Alireza Fazeli, Action Vice‐Chair, UK
Milena Mourdjeva, MC Member, Bulgaria
Elena Kistanova, Substitute MC Member, Bulgaria
Soren Hayrabedyan, Scientific Secretary of IBIR ‐BAS, Bulgaria
Radostina Aleksandorova, MC Member, Bulgaria
Markus Rimann, Switzerland